Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Susana, Sainz de la Maza"'
Autor:
Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, Julia Gracia-Gil, Eva Fernández, Virginia Meca-Lallana, Carolina Díaz-Pérez, Susana Sainz de la Maza, Eva María Pacheco, Ana Quiroga, Lluis Ramió-Torrentà, Sergio Martínez-Yélamos, Laura Bau, Enric Monreal, Ana López-Real, Alexander Rodero-Romero, Laura Borrega, Santiago Díaz, Pablo Eguía, Mercedes Espiño, Juan Luis Chico-García, Francisco Javier Barrero, María Luisa Martínez-Ginés, José Manuel García-Domínguez, Soraya De la Fuente, Irene Moreno, Raquel Sainz-Amo, M. Alba Mañé-Martínez, Ana Caminero, Fernando Castellanos, Ana Gómez López, Andrés Labiano-Fontcuberta, Lucía Ayuso, Rossana Abreu, Miguel Ángel Hernández, José Meca-Lallana, Lorena Martín-Aguilar, Alfonso Muriel García, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveTo ascertain the changes of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) values in relapsing–remitting multiple sclerosis (RRMS) patients treated with ocrelizumab and their association with treatment r
Externí odkaz:
https://doaj.org/article/d000198e5e11421c9eafc7ac50f33ed2
Autor:
Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Raquel Sainz-Amo, Lucienne Costa-Frossard, Jaime Masjuan, Luisa María Villar
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveTo evaluate the safety of COVID-19 vaccines in patients with multiple sclerosis (MS) by assessing their impact on serum neurofilament light chain (sNfL) levels as a marker of neuroaxonal damage.MethodsSingle-center observational longitudinal
Externí odkaz:
https://doaj.org/article/042d07f429b0483597015d2e09baa5d8
Autor:
Raquel Sainz-Amo, Alexander Rodero Romero, Enric Monreal, Juan Luis Chico García, José Ignacio Fernández Velasco, Noelia Villarrubia, Jose Luis Veiga González, Susana Sainz de la Maza, Fernando Rodríguez Jorge, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionAlemtuzumab is a highly effective pulsed immune reconstitution therapy for multiple sclerosis (MS).AimTo evaluate serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) in patients with relapsing-remittin
Externí odkaz:
https://doaj.org/article/dd92d345eae2484390381b8e9f58bd9e
Autor:
Juan Pablo Cuello, Ariana Meldaña Rivera, Enric Monreal, Ana Gómez Lozano, Ana Maria García Cano, Jose Manuel García Domínguez, José Ignacio Fernández Velasco, Lucienne Costa-Frossard França, Haydee Goicochea, Yolanda Higueras, Juan Antonio De León-Luis, Susana Sainz De La Maza, Noelia Villarrubia, Ignacio Arribas Gómez, Irene Ruiz Perez, Maria Luisa Martinez Ginés, Luisa María Villar
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundPatient disability, relapse rate, and age are used for family planning in multiple sclerosis (MS). However, the need for more accurate biomarkers is widely recognized. We aimed to explore the influence of age on neurofilament light chain (s
Externí odkaz:
https://doaj.org/article/56e3c2e4d1bc47e0a4e89da81a6b0857
Autor:
Enric Monreal, José Ignacio Fernández-Velasco, Ana García-Soidán, Susana Sainz de la Maza, Mercedes Espiño, Noelia Villarrubia, Fernando Rodríguez-Jorge, Juan Luís Chico-García, Raquel Sainz-Amo, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe immunoglobulin kappa free light chain (KFLC) index has been proposed as a potentially suitable alternative to oligoclonal IgG bands (OCGB) for diagnosing multiple sclerosis (MS), offering automation and reduced processing time. Howeve
Externí odkaz:
https://doaj.org/article/c856cfa855b74d99a369be3e14854d57
Autor:
Alexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, Enric Monreal, Paulette Esperanza Walo-Delgado, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, Rafael Rodríguez-Ramos, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Publikováno v:
Vaccines, Vol 11, Iss 9, p 1399 (2023)
This single-center study included 68 multiple sclerosis (MS) patients who received the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination from one of several approved vaccine preparations in Spain. Blood samples were collected o
Externí odkaz:
https://doaj.org/article/4d8709038bee489ea32a0e871e762155
Autor:
Paulette Esperanza Walo-Delgado, Susana Sainz de la Maza, Noelia Villarrubia, Enric Monreal, Silvia Medina, Mercedes Espiño, José Ignacio Fernández-Velasco, Eulalia Rodríguez-Martín, Ernesto Roldán, Daniel Lourido, Alfonso Muriel, Jaime Masjuan-Vallejo, Lucienne Costa-Frossard, Luisa María Villar
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Serum neurofilament light chains (sNfL) are biomarkers of disease activity in multiple sclerosis (MS), but their value to predict response to treatment, and their association with patient immunological profile, need to be further explored. W
Externí odkaz:
https://doaj.org/article/8c728d8ae2de49b8accdc64e3ffacaf7
Autor:
Susana Sainz de la Maza, Paulette Esperanza Walo-Delgado, Mario Rodríguez-Domínguez, Enric Monreal, Alexander Rodero-Romero, Juan Luis Chico-García, Roberto Pariente, Fernando Rodríguez-Jorge, Rubén Ballester-González, Noelia Villarrubia, Beatriz Romero-Hernández, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Publikováno v:
Vaccines, Vol 11, Iss 4, p 786 (2023)
Background: This study aimed to evaluate short- and long-term humoral and T-cell-specific immune responses to SARS-CoV-2 vaccines in patients with multiple sclerosis (MS) treated with different disease-modifying therapies (DMTs). Methods: Single-cent
Externí odkaz:
https://doaj.org/article/e47df56766a24d768e19edea261665bc
Autor:
José I. Fernández-Velasco, Enric Monreal, Jens Kuhle, Virginia Meca-Lallana, José Meca-Lallana, Guillermo Izquierdo, Celia Oreja-Guevara, Francisco Gascón-Giménez, Susana Sainz de la Maza, Paulette E. Walo-Delgado, Paloma Lapuente-Suanzes, Aleksandra Maceski, Eulalia Rodríguez-Martín, Ernesto Roldán, Noelia Villarrubia, Albert Saiz, Yolanda Blanco, Carolina Diaz-Pérez, Gabriel Valero-López, Judit Diaz-Diaz, Yolanda Aladro, Luis Brieva, Cristina Íñiguez, Inés González-Suárez, Luis A Rodríguez de Antonio, José M. García-Domínguez, Julia Sabin, Sara Llufriu, Jaime Masjuan, Lucienne Costa-Frossard, Luisa M. Villar
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectiveTo ascertain the role of inflammation in the response to ocrelizumab in primary-progressive multiple sclerosis (PPMS).MethodsMulticenter prospective study including 69 patients with PPMS who initiated ocrelizumab treatment, classified accord
Externí odkaz:
https://doaj.org/article/c8e040513ca84c5f9b5252521e717dd6
Autor:
Paulette Esperanza Walo-Delgado, Enric Monreal, Silvia Medina, Ester Quintana, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, Paloma Lapuente, Manuel Comabella, Lluis Ramió-Torrentà, Xavier Montalban, Luciana Midaglia, Noelia Villarrubia, Angela Carrasco-Sayalero, Eulalia Rodríguez-Martín, Ernesto Roldán, José Meca-Lallana, Roberto Alvarez-Lafuente, Jaime Masjuan, Lucienne Costa-Frossard, Luisa Maria Villar
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectiveTo explore if baseline blood lymphocyte profile could identify relapsing remitting multiple sclerosis (RRMS) patients at higher risk of developing secondary autoimmune adverse events (AIAEs) after alemtuzumab treatment.MethodsMulticenter pro
Externí odkaz:
https://doaj.org/article/db6b5f4929b24c10a2068757d7ba4fb7